MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Melt Pharmaceuticals (MELT)
Organization & Developments: Melt Pharmaceuticals
Parents
Melt Pharmaceuticals (MELT)
Children
Lead candidate is MELT-300, a fixed dose combination of midazolam and ketamine in a fast-dissolving tablet that is administered sublingually for procedural sedation and analgesia during cataract surgery
The firm is a clinical stage biopharma developing drug candidates for sedation and acute pain.
Jumps
Finance & Acquisition: Melt Pharmaceuticals
Key People: Melt Pharmaceuticals